Your session is about to expire
← Back to Search
Auditory Stimulation for Rolandic Epilepsy
N/A
Recruiting
Led By Catherine Chu, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has had at least 1 focal motor or generalized seizure
Diagnosed with childhood epilepsy with centrotemporal spikes (CECTS) or Rolandic epilepsy by child neurologist
Must not have
Over MRI weight limit: 350lbs
History of frequent vomiting
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-5 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial is for children with Rolandic epilepsy and those without it, to see how different brain imaging techniques show brain activity in children with epilepsy.
Who is the study for?
This trial is for children aged 4-18 with Rolandic epilepsy, who've had at least one seizure and show specific brain activity patterns on an EEG. It's not for those with abnormal MRIs, other neurological diseases, metal implants or braces, claustrophobia, a history of frequent vomiting, or over the MRI weight limit.
What is being tested?
The study is testing auditory stimulation in kids with Rolandic epilepsy using non-invasive brain imaging techniques like MRI and MEG/EEG to understand affected brain circuits and rhythms. The goal is to find new treatments for childhood epilepsy.
What are the potential side effects?
Since this trial involves non-invasive imaging and experimental tasks without medication intervention, significant side effects are not expected. However, discomfort from wearing EEG equipment or lying still during scans may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had at least one seizure.
Select...
I have been diagnosed with Rolandic epilepsy by a child neurologist.
Select...
I am between 4 and 18 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I weigh less than or equal to 350lbs.
Select...
I often experience vomiting.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-5 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-5 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Memory performance
Spindle Density
Other study objectives
Spindle-slow oscillation coupling
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Children and adolescents with epilepsy and controlsExperimental Treatment1 Intervention
Closed loop auditory stimulation during nap
Find a Location
Who is running the clinical trial?
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,378 Previous Clinical Trials
652,092 Total Patients Enrolled
79 Trials studying Epilepsy
25,463 Patients Enrolled for Epilepsy
Boston UniversityOTHER
472 Previous Clinical Trials
9,987,733 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
3,015 Previous Clinical Trials
13,309,260 Total Patients Enrolled
8 Trials studying Epilepsy
538 Patients Enrolled for Epilepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I weigh less than or equal to 350lbs.I often experience vomiting.You cannot have a magnetic resonance imaging (MRI) or magnetoencephalography (MEG) scan.You have permanent metal in your body, such as braces.You have an unusual brain MRI.I have had at least one seizure.You have a different neurological disease not related to the study.You have a specific abnormal brain wave pattern during sleep.You feel very uncomfortable in small or crowded spaces.I have been diagnosed with Rolandic epilepsy by a child neurologist.I am between 4 and 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Children and adolescents with epilepsy and controls
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger